Should Digoxin Continue To Be Used for the Management of Atrial Fibrillation?
出版信息
Can J Hosp Pharm. 2017 Sep-Oct;70(5):391-394. doi: 10.4212/cjhp.v70i5.1701. Epub 2017 Oct 31.
Abstract
摘要
相似文献
1
Should Digoxin Continue To Be Used for the Management of Atrial Fibrillation?地高辛是否应继续用于心房颤动的治疗？
Can J Hosp Pharm. 2017 Sep-Oct;70(5):391-394. doi: 10.4212/cjhp.v70i5.1701. Epub 2017 Oct 31.
2
Digoxin for atrial fibrillation: a drug whose time has gone?
Ann Intern Med. 1991 Apr 1;114(7):573-5. doi: 10.7326/0003-4819-114-7-573.
3
Physician variation in the management of patients with atrial fibrillation.心房颤动患者管理中的医生差异。
Heart. 1996 Feb;75(2):200-5. doi: 10.1136/hrt.75.2.200.
4
Is there a role for digoxin in atrial fibrillation without heart failure?地高辛在无心力衰竭的心房颤动中是否有作用？
Cardiol J. 2009;16(5):483-6.
5
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.地高辛与成人房颤患者的死亡风险：ATRIA-CVRN研究
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):49-58. doi: 10.1161/CIRCEP.114.002292. Epub 2014 Nov 20.
6
Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.地高辛与安慰剂、无干预措施或其他用于心房颤动和心房扑动的医学干预措施的比较：一项系统评价、荟萃分析和试验序贯分析的方案
Syst Rev. 2017 Apr 5;6(1):71. doi: 10.1186/s13643-017-0470-2.
7
Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.地高辛“治疗性”血清水平在控制房颤心室率方面无效。
Am J Cardiol. 1975 May;35(5):651-5. doi: 10.1016/0002-9149(75)90051-x.
8
Distribution of fast heart rate episodes during paroxysmal atrial fibrillation.阵发性心房颤动期间快速心率发作的分布情况。
Heart. 1998 May;79(5):497-501. doi: 10.1136/hrt.79.5.497.
9
Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
Am J Cardiol. 1998 Sep 1;82(5):584-8. doi: 10.1016/s0002-9149(98)00412-3.
10
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.急性心房颤动患者静脉注射地高辛：基于急性心房颤动地高辛试验的群体药代动力学/药效学分析
Eur J Clin Pharmacol. 2003 Mar;58(11):747-55. doi: 10.1007/s00228-002-0553-3. Epub 2003 Feb 19.
引用本文的文献
1
Postoperative Atrial Fibrillation Following Anatomic Lung Resection: A Case Report and Narrative Review of Contemporary Pharmacologic Management.解剖性肺切除术后的心房颤动：一例病例报告及当代药物治疗的叙述性综述
Cureus. 2025 Aug 5;17(8):e89426. doi: 10.7759/cureus.89426. eCollection 2025 Aug.
2
Review: Failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy.综述：当前地高辛毒性监测的失败：维持治疗水平以确保疗效的新监测建议。
Front Cardiovasc Med. 2023 Jul 3;10:1179892. doi: 10.3389/fcvm.2023.1179892. eCollection 2023.
3
Comparative effectiveness of common treatments for new-onset atrial fibrillation within the ICU: Accounting for physiological status.比较 ICU 中新发心房颤动常见治疗方法的效果：考虑生理状态。
J Crit Care. 2022 Feb;67:149-156. doi: 10.1016/j.jcrc.2021.11.005. Epub 2021 Nov 16.
本文引用的文献
1
Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.地高辛与安慰剂、无干预措施或其他用于心房颤动和心房扑动的医学干预措施的比较：一项系统评价、荟萃分析和试验序贯分析的方案
Syst Rev. 2017 Apr 5;6(1):71. doi: 10.1186/s13643-017-0470-2.
2
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.《加拿大心血管学会心房颤动管理指南2016年重点更新》
Can J Cardiol. 2016 Oct;32(10):1170-1185. doi: 10.1016/j.cjca.2016.07.591. Epub 2016 Sep 6.
3
Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.心房颤动患者死亡率与地高辛使用情况的系统评价和荟萃分析
Cardiol J. 2016;23(3):333-43. doi: 10.5603/CJ.a2016.0016. Epub 2016 Apr 11.
4
Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality.地高辛用于控制心房颤动和心力衰竭患者的心室率与死亡率增加无关。
Cardiol Res Pract. 2015;2015:314041. doi: 10.1155/2015/314041. Epub 2015 Dec 14.
5
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.地高辛的安全性和有效性：观察性和对照试验数据的系统评价与荟萃分析
BMJ. 2015 Aug 30;351:h4451. doi: 10.1136/bmj.h4451.
6
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.当代房颤队列患者中地高辛的使用及后续结局
J Am Coll Cardiol. 2015 Jun 30;65(25):2691-8. doi: 10.1016/j.jacc.2015.04.045.
7
Digoxin-associated mortality: a systematic review and meta-analysis of the literature.地高辛相关死亡率：文献系统评价和荟萃分析。
Eur Heart J. 2015 Jul 21;36(28):1831-8. doi: 10.1093/eurheartj/ehv143. Epub 2015 May 4.
8
Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation.地高辛使用与心房颤动患者死亡风险的Meta分析。
Am J Cardiol. 2015 Apr 1;115(7):901-6. doi: 10.1016/j.amjcard.2015.01.013. Epub 2015 Jan 14.
9
Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.地高辛与成人房颤患者的死亡风险：ATRIA-CVRN研究
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):49-58. doi: 10.1161/CIRCEP.114.002292. Epub 2014 Nov 20.
10
Interaction between digoxin and dronedarone in the PALLAS trial.在PALLAS试验中地高辛与决奈达隆的相互作用。
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.
Zotero 插件